Although several datasets from Gene Expression Omnibus (GEO), such as GSE40595, GSE35250, and GSE14407, indicate the downregulation of OGN in ovarian cancer, the specific effect of OGN on ovarian cancer remains unclear. This evidence concerns the gene OGN and ovarian carcinoma.